Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 1/20 | 0.46 |
| ▸ | DHODH | Q02127 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | NCEH1 | Q6PIU2 | 1/20 | 0.43 |
| ▸ | CES2 | O00748 | 2/20 | 0.43 |
| ▸ | CES1 | P23141 | 2/20 | 0.43 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | KDM2B | Q8NHM5 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22479104 | 0.94 | CYP2A6 (0.45) | CYP2A6DHODHKDM4EMEN1ALDH1A1 | |
| SCHEMBL30515106 | 0.94 | CYP2A6 (0.45) | CYP2A6DHODHKDM4EMEN1ALDH1A1 | |
| SCHEMBL25334269 | 0.90 | CYP2A6 (0.42) | CYP2A6DHODHKDM4EMEN1ALDH1A1 | |
| SCHEMBL727139 | 0.87 | CES2 (0.52) | CYP2A6KDM4EMEN1ALDH1A1MAPT | |
| SCHEMBL29375279 | 0.87 | CES2 (0.52) | CYP2A6KDM4EMEN1ALDH1A1MAPT | |
| SCHEMBL8775402 | 0.82 | LCK (0.48) | CYP2A6KDM4EMEN1ALDH1A1MAPT | |
| SCHEMBL203205 | 0.81 | DHODH (0.55) | CYP2A6DHODHKDM4EMEN1ALDH1A1 | |
| SCHEMBL30020656 | 0.81 | DHODH (0.55) | CYP2A6DHODHKDM4EMEN1ALDH1A1 | |
| SCHEMBL1681902 | 0.80 | CES2 (0.50) | CYP2A6KDM4EMEN1ALDH1A1MAPT | |
| SCHEMBL264367 | 0.79 | CYP2A6 (0.55) | CYP2A6DHODHKDM4EMEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 148 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111636208-B | Mesoporous hydrogen bond organic framework fiber composite material and preparation method and application thereof | 李鹏 | 2022-10-11 | — | — | CN | claimed |
| CN-111636208-A | Mesoporous hydrogen bond organic framework fiber composite material and preparation method and application thereof | 李鹏 | 2020-09-08 | — | — | CN | claimed |
| US-12258353-B2 | Heterocyclic compound and organic light-emitting element including same | LT MATERIALS CO., LTD. (KR) | 2025-03-25 | — | — | US | disclosed |
| CN-113166171-B | Heterocyclic compound and organic light-emitting device comprising the same | LT素材株式会社 | 2024-05-14 | — | — | CN | disclosed |
| EP-3561892-B1 | ORGANIC LIGHT-EMITTING DEVICE | LT MATERIALS CO LTD (KR) | 2023-05-10 | — | — | EP | disclosed |
| CN-111636208-B | Mesoporous hydrogen bond organic framework fiber composite material and preparation method and application thereof | 李鹏 | 2022-10-11 | — | — | CN | disclosed |
| US-20220033415-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT INCLUDING SAME | LT MATERIALS CO., LTD. (KR) | 2022-02-03 | — | — | US | disclosed |
| CN-113166171-A | Heterocyclic compound and organic light-emitting device comprising the same | LT素材株式会社 | 2021-07-23 | — | — | CN | disclosed |
| CN-106588890-B | Antiviral compounds | 吉利德制药有限责任公司 | 2020-11-27 | — | — | CN | disclosed |
| CN-111636208-A | Mesoporous hydrogen bond organic framework fiber composite material and preparation method and application thereof | 李鹏 | 2020-09-08 | — | — | CN | disclosed |
| WO-2020116995-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT INCLUDING SAME | 엘티소재주식회사 | 2020-06-11 | — | — | WO | disclosed |
| WO-2002040484-A2 | NOVEL IMIDAZOLE DERIVATIVES, PRODUCTION METHOD THEREOF AND USE THEREOF | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2002-05-23 | — | — | WO | disclosed |
| US-5116830-A | Stereoisomerically pure 17α-ethynyl-estra-2-en-17β-ol and the 17β esters thereof, methods of preparation and uses | SRI INTERNATIONAL (US) | 1992-05-26 | — | — | US | disclosed |
| EP-0190149-B1 | STEREOISOMETRICALLY PURE 17-ALPHA-ETHYNYL-ESTRA-2-EN-17BETA-OL AND ESTERS THEREOF | SRI INTERNATIONAL (US) | 1989-12-13 | — | — | EP | disclosed |
| US-4788218-A | MALE FERTILITY CONTROL | SRI INTERNATIONAL (US) | 1988-11-29 | — | — | US | disclosed |
| EP-0190149-A1 | STEREOISOMETRICALLY PURE 17-ALPHA-ETHYNYL-ESTRA-2-EN-17BETA-OL AND ESTERS THEREOF. | STANFORD RES INST INT (US) | 1986-08-13 | — | — | EP | disclosed |
| EP-0182808-A1 | 17 a?$g(b)-HYDROXY-7$g(a)-METHYL-D-HOMO-19-NORANDROST-4,16-DIENE-3-ONE AND THE 17-ESTERS THEREOF: METHODS OF PREPARATION AND USES | SRI INTERNATIONAL (US) | 1986-06-04 | — | — | EP | disclosed |
| WO-1986001208-A1 | STEREOISOMETRICALLY PURE 17-ALPHA-ETHYNYL-ESTRA-2-EN-17BETA-OL AND ESTERS THEREOF | SRI INTERNATIONAL (US) | 1986-02-27 | — | — | WO | disclosed |
| WO-1985005361-A1 | 17abeta-HYDROXY-7alpha-METHYL-D-HOMO-19-NORANDROST-4,16-DIENE-3-ONE AND THE 17-ESTERS THEREOF: METHODS OF PREPARATION AND USES | SRI INTERNATIONAL (US) | 1985-12-05 | — | — | WO | disclosed |
| US-3948939-A | 9-Acyl-1,2,3,4-tetrahydrocarbazole-3 and 4-carboxylic acids | STERLING DRUG INC. (US) | 1976-04-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220033415-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT INCLUDING SAME | CRY1, CRY2, LEF1 | CYP2A6 91/4885DHODH 328/4885KDM4E 2194/4885 |
| US-12258353-B2 | Heterocyclic compound and organic light-emitting element including same | CRY1, CRY2, LEF1 | CYP2A6 91/4885DHODH 328/4885KDM4E 2194/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.